Mkts

Tenax Therapeutics, Inc.

NASDAQ: TENX
$1.81-0.03 (-1.63%)
As of Nov 4, 4:00 PM ET

Key statistics

Day range
1.741.88
52-week range
1.3119.40
Today
Open1.85
Previous close1.81
Volume162.2K
Valuation
Market cap68.86M
P/E ratio—
EPS (TTM)-1.47
Income & risk
Dividend / yield—
Beta1.03
Avg volume4.45M
Discussion

TENX News

Stories mentioning TENX from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue0.000.00
Cost of Goods Sold
Gross Profit0.000.000.000.00
Operating Expenses
Research & Development11,53910,54010,3286,1215,6834,5943,1122,327
Sales General & Admin
Total Operating Expenses16,57316,44916,80611,79211,3387,2954,6193,671
Operating Income (Loss)(16,573)(16,449)(16,806)(11,792)(11,338)(7,295)(4,619)(3,671)
Interest Income
Interest Expense(1.00)7.009.00
Other Expense(4.00)(9.00)(15.00)(9.00)0.00117.000.001.00
Pretax Income
Tax Provision
Net Income (Loss)(15,716)(15,540)(15,804)(10,847)(10,408)(6,267)(3,961)(3,575)
Earnings Per Share (Basic)(0.35)(0.40)(0.40)(0.27)(0.28)(0.41)(0.19)(1.83)
Earnings Per Share (Diluted)(0.35)(0.40)(0.40)(0.27)(0.28)(0.41)(0.19)(1.83)
Weighted Average Shares Outstanding (Basic)45,22639,21739,74139,57236,58515,27221,1611,958
Weighted Average Shares Outstanding (Diluted)45,22639,21739,74139,57236,58515,27221,1611,958

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About TENX

Tenax Therapeutics, Inc. (NASDAQ: TENX) is a stock listed on the Nasdaq Stock Market under the ticker symbol TENX. It last traded at $1.81 (Nov 4, 2026, 4:00 PM ET), down 1.6% on the day. That gives Tenax Therapeutics a market capitalisation of $68.9M.

Over the past 52 weeks TENX has traded between $1.31 and $19.40.

Revenue for the quarter ended Mar 31, 2026 was $0; a net loss of $15.7M.

Last 4 quarters
Quarter endedRevenueNet income
Mar 31, 2026$0-$15.7M
Dec 31, 2025—-$15.5M
Sep 30, 2025—-$15.8M
Jun 30, 2025—-$10.8M

From Tenax Therapeutics’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…